Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript August 1, 2024Aurinia Pharmaceuticals Inc. misses on earnings expectations.
Aurinia Pharmaceuticals Inc. (AUPH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 11,136,000 | $63,586,560 | -10% | 0.8% |
| 2. | Tang Capital Management Kevin C. Tang | 2,779,500 | $15,870,945 | +36% | 1.61% |
| 3. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 1,179,740 | $6,736,315 | +3% | 0.2% |
| 4. | Citadel Investment Group Ken Griffin | 937,792 | $5,354,792 | +250% | 0% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 614,066 | $3,506,317 | +23% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.91 | 20,000 | Director | 70,000 | 2023-03-02 | Filing | |
| $4.66 | 10,000 | Officer | 27,927 | 2022-11-21 | Filing | |
| $5.02 | 5,000 | Officer | 5,000 | 2022-11-09 | Filing | |
| $5.16 | 30,000 | Officer | 89,512 | 2022-11-07 | Filing | |
| $11.00 | 5,000 | Director | 11,000 | 2022-03-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.31 | 18,249 | Officer | 456,338 | 2024-08-06 | Filing | |
| $5.74 | 520 | Director | 17,523 | 2024-05-21 | Filing | |
| $5.74 | 5,252 | Director | 28,141 | 2024-05-21 | Filing | |
| $5.74 | 4,946 | Director | 44,364 | 2024-05-21 | Filing | |
| $5.74 | 5,610 | Director | 12,918 | 2024-05-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,921,049 | $80,200,231 | 0% | |
| 2. | 3,969,834 | $35,688,808 | 2.37% | |
| 3. | 2,704,382 | $24,312,394 | 0% | |
| 4. | 2,352,125 | $21,145,604 | 0% | |
| 5. | 2,048,456 | $18,415,619 | 0% |
News See All
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.
11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.18.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to Aurinia Pharmaceuticals Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
13 Stocks to Buy with Exponential Growth
Optimism was prevailing in the US stock market on October 11 as investors were hopeful that the Federal Reserve won’t take a hawkish stance for the rest of the year amid rising bond yields that are ...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2023 Earnings Call Transcript
Operator: Greetings. And welcome to Aurinia Pharmaceuticals Incorporated Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Aurinia Pharmaceuticals Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Aurinia Pharmaceuticals Fourth Quarter and Full Year 2022 Results Conference Call. At this time all participants are in a listen-only mode.
Hedge Fund and Insider Trading News: Bill Ackman, Nelson Peltz, Steven Cohen, Hestia Capital Partners, AQR Capital Management, Solo Capital Partners, Aurinia Pharmaceuticals Inc. (AUPH), Intel Corporation (INTC), and More
Billionaire investor and hedge fund manager Bill Ackman says he remains bullish about cryptocurrencies, despite the recent collapse of the FTX cryptocurrency exchange and the market turmoil that has followed...
Billionaire Hedge Funds
